- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02012374
Overcoming Learned Non-Use in Chronic Aphasia
December 19, 2022 updated by: University of Massachusetts, Amherst
Overcoming Learned Non-Use in Chronic Aphasia: Behavioral, fMRI and QoL Outcomes
In this study the investigators are examining the effectiveness of intensive speech therapy in chronic moderate-to-severe stroke-induced aphasia under two conditions - responses "constrained" or unconstrained to speech.
Both treatments involve massed practice communicating, using intensive language action therapy 3 hours/day, 5 days/week for two weeks, followed by six months of a home practice program.
One treatment stresses spoken responses as the preferred expressive modality during intensive therapy.
Before and after treatment, and following the home practice program and a period of no practice, the investigators will administer several tests and discourse samples to examine changes associated with the treatments.
Participants will also undergo structural and functional MRI testing at these time points.
The investigators will also attempt to quantify the degree to which improvements following intensive language therapy and home practice correlate with changes in Quality of Life measures as perceived by both participants with aphasia and their significant others.
It is hypothesized that, whereas both treatments will lead to improvements in naming practiced words and communicating, outcomes will be enhanced for the group randomly assigned to the "constraint" condition.
Moreover, performance will be enhanced on words practiced during the home practice program, including those that were not practiced during intensive therapy.
Improved naming will correlate with modulation of 'signature' language and attentional networks, whose variability will depend on remaining viable brain structures.
Initial severity and site/extent of lesion should predict patients' ability to transfer gains in naming to improvements in discourse.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Amherst, Massachusetts, United States, 01003
- University of Massachusetts Amherst
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 88 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- unilateral left hemisphere stroke at least 6 months earlier
- aphasia with moderate-to-severe word retrieval impairments
- at least 21 years of age
- premorbidly right handed
- native speaker of English
Exclusion Criteria:
- history of developmental learning difficulties
- history of prior neurological illnesses
- chronic medical illnesses that restrict participation in intensive therapy
- recent alcohol or drug dependence
- severe uncorrected impairments of vision or hearing
- any contraindication to a 3T MRI procedure (e.g., claustrophobia, metal implants or fragments in body, pregnancy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intensive Language Action Therapy ("constrained")
Following a phase of baseline pre-treatment testing, speech therapy sessions take place 5 days/week for 3 hours per session during two consecutive weeks.
Spoken responses are explicitly modeled and encouraged during therapy.
Following the intensive 2-week treatment, participants are trained in using individualized home practice programs on iPads.
They practice approximately daily for six months, checking in weekly with an SLP via videoconferencing software and return for probes monthly.
Six months post-treatment testing will take place following completion of the home practice phase and again at 12 months post-treatment.
|
|
Experimental: Unconstrained Intensive Language Action Therapy
Following a phase of baseline pre-treatment testing, speech therapy sessions take place 5 days/week for 3 hours per session during two consecutive weeks.
All communicative responses are encouraged during therapy.
Following the intensive 2-week treatment, participants are trained in using individualized home practice programs on iPads.
They practice approximately daily for six months, checking in weekly with an SLP via videoconferencing software and return for probes monthly.
Six months post-treatment testing will take place following completion of the home practice phase and again at 12 months post-treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
• Change from baseline on Confrontation Naming Task
Time Frame: Change will be assessed immediately post-treatment (2 weeks)
|
Change will be assessed immediately post-treatment (2 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline Boston Diagnostic Aphasia Examination
Time Frame: Change will be assessed immediately post-treatment (2 weeks)
|
Change will be assessed immediately post-treatment (2 weeks)
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline Boston Naming Test
Time Frame: Change will be assessed immediately post-treatment (2 weeks)
|
Change will be assessed immediately post-treatment (2 weeks)
|
Change from baseline discourse samples
Time Frame: Change will be assessed post-home practice program (approx. 6 months)
|
Change will be assessed post-home practice program (approx. 6 months)
|
Change from baseline Assessment of Living with Aphasia
Time Frame: Change will be assessed post-home practice program (approx. 6 months
|
Change will be assessed post-home practice program (approx. 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jacquie Kurland, Ph.D., UMass Amherst
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 26, 2012
Primary Completion (Actual)
March 17, 2015
Study Completion (Actual)
July 9, 2015
Study Registration Dates
First Submitted
February 12, 2013
First Submitted That Met QC Criteria
December 9, 2013
First Posted (Estimate)
December 16, 2013
Study Record Updates
Last Update Posted (Estimate)
December 20, 2022
Last Update Submitted That Met QC Criteria
December 19, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-1065
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke-induced Aphasia
-
University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Aphasia | Stroke, Ischemic | Aphasia, Broca | Aphasia, Anomic | Aphasia, Global | Aphasia, Fluent | Aphasia, Mixed | Aphasia, Jargon | Aphasia, Expressive | Aphasia, ConductionUnited States
-
Assiut UniversityCompletedNon Fluent Aphasia in Subacute Stroke
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
All India Institute of Medical Sciences, New DelhiVardhman Mahavir Medical College And Safdarjung Hospital; Institute of Human... and other collaboratorsNot yet recruitingAphasia, Broca | Stroke Rehabilitation
-
Institute of Psychiatry and Neurology, WarsawRecruitingStroke, Ischemic | Aphasia Non FluentPoland
-
University of CalgaryCompletedStroke | Aphasia, Non-fluentCanada
-
University of PennsylvaniaNot yet recruiting
-
Scion NeuroStimDuke UniversityCompletedPost-stroke AphasiaUnited States
-
Pace UniversityEmory UniversityNot yet recruitingDepressive Disorder | Stroke, Acute | Movement, Abnormal | Expressive Aphasia
Clinical Trials on Intensive Language Action Therapy
-
Charite University, Berlin, GermanyGerman Federal Ministry of Education and ResearchUnknownPost-Stroke Chronic Aphasia | Anomia (Word-retrieval Impairment)Germany
-
Charité Neurocure AG FlöelUnknownAphasia | Anomia (Word-Finding Impairment)Germany
-
Paula HeikkinenFreie Universität Berlin; Aalto University; Hospital District of Helsinki and...Completed
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RecruitingPrimary Progressive Aphasia | Logopenic Progressive Aphasia | Non-Fluent Primary Progressive AphasiaUnited States, Canada
-
Assiut UniversityCompleted
-
University College, LondonCompletedLanguage Difficulties in British Sign Language
-
Johns Hopkins UniversityActive, not recruitingPrimary Progressive AphasiaUnited States
-
Samsung Medical CenterCompletedStroke | Rehabilitation | LanguageKorea, Republic of
-
Johns Hopkins UniversityNational Institutes of Health (NIH); National Institute on Deafness and Other...RecruitingPrimary Progressive Aphasia | MCI | FTDUnited States